Fitness of Toxoplasma gondii is not related to DHFR single-nucleotide polymorphism during congenital toxoplasmosis

International Journal for Parasitology

Volumn 34, Issue 10, 2004, Pages 1169-1175

  Peyron, François ^a,b   Eudes, Nathalie ^a   De Monbrison, Frédérique ^a,c   Wallon, Martine ^b   Picot, Stéphane ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Congenital toxoplasmosis; DHFR; Fitness; SNP; Toxoplasma gondii

Indexed keywords

DIHYDROFOLATE REDUCTASE;

PARASITOLOGY; TOXOPLASMOSIS;

ALLELE; AMNION FLUID; ARTICLE; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; FETUS; FETUS OUTCOME; HUMAN; HYBRIDIZATION; MEDICAL INSTRUMENTATION; MOLECULAR PROBE; NEWBORN; PARASITE VIRULENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; TOXOPLASMA GONDII;

ANIMALS; BASE SEQUENCE; DNA, PROTOZOAN; DRUG RESISTANCE; GENES, PROTOZOAN; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ALIGNMENT; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; VIRULENCE;

TOXOPLASMA GONDII;

EID: 4544385676     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2004.05.009     Document Type: Article

References (28)

1. Araujo F.G., Shepard R.M., Remington J.S. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii. Eur. J. Clin. Microb. Infect. Dis. 10:1991;519-524
2. Aspinall T.V., Joynson D.H.M., Guy E., Hyde J.E., Sims P.F.G. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J. Infect. Dis. 185:2002;1637-1643
3. Baril L., Ancelle T., Goulet V., Thulliez P., Tirard Fleury V., Carme B. Risk factor for Toxoplasma infection in pregnancy: a case control study in France. Scand. J. Infect. Dis. 31:1999;305-309
4. Bates M., Wrin T., Huang W., Petropoulos C., Hellmann N. Practical applications of viral fitness in clinical practice. Curr. Opin. Infect. Dis. 16:2003;11-18
5. Boothroyd J.C., Grigg M.E. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr. Opin. Microbiol. 4:2002;438-442
6. Combes C. Fitness of parasites: pathology and selection. Int. J. Parasitol. 27:1997;1-10
7. Coustau C., Chevillon C., Ffrench-Constant R. Resistance to xenobiotics and parasites: can we count the cost? Trends Ecol. Evol. 15:2000;378-383
8. de Monbrison F., Raynaud D., Latour-Fondanaiche C., Staal A., Favre S., Kaiser K., Peyron F., Picot S. Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum. J. Microbiol. Methods. 54:2003;391-401
9. Doumbo O.K., Kayentao K., Djimde A., Cortese J.F., Diourte Y., Konare A., Kublin J.G., Plowe C.V. Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. J. Infect. Dis. 182:2000;993-996
10. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C., Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 353:1999;1829-1833
11. Fohl L.M., Roos D.S. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites. Mol. Microbiol. 50:2003;1319-1327
12. Foreman-Wykert A.K., Miller J.F. Hypervirulence and pathogen fitness. Trends Microbiol. 11:2003;105-108
13. Fuentes I., Rubio J.M., Ramirez C., Alvar J. Genotypic characterisation of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J. Clin. Microbiol. 39:2001;1556-1570
14. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184:2001;633-639
15. Howe D.K., Sibley L.D. Toxoplasma gondi comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1995;1561-1566
16. Kissinger J.C., Gajria B., Li L., Paulsen I.T., Roos D.S. ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res. 31:2003;234-236
17. Lebech M., Joynson D.H., Seitz H.M., Thulliez P., Gilbert R.E., Dutton G.N., Ovlisen B., Petersen E. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;799-805
18. Luft B.J., Hafner R., Korzun A.H., Antoniskis D., Bosler E.M., Bourland D.D., Uttamchandani R., Fuhrer J., Jacobson J., Morlat P., Vilde J.L., Remington J.S. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 329:1993;995-1000
19. McLeod R., Dowel M. Basic immunology: the fetus and the newborn. Ambroise-Thomas P., Petersen E. Congenital Toxoplasmosis. 2000;37-68 Springer, Paris
20. Peyron F., Wallon M. Options for the pharmacotherapy of toxoplasmosis during pregnancy. Expert Opin. Pharmacother. 2:2001;1269-1274
21. Peyron F., Wallon M., Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N. Engl. J. Med. 334:1996;993-994
22. Reynolds M.G., Oh J., Roos D.S. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase. Antimicrob. Agents Chemother. 45:2001;1271-1277
23. Roman S., Chosson M., Franck J., Wallon M., Kieffer F., Kaiser K., Dumon H., Peyron F., Thulliez P., Picot S. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with T. gondii. Am. J. Obstet. Gynecol. 190:2004;797-802
24. Shapira S., Harb O.S., Caamano J., Hunter C.A. The NF-κB signaling pathway: immune evasion and immunoregulation during toxoplasmosis. Int. J. Parasitol. 34:2004;393-400
25. Sibley L.D., Mordue D., Howe D.K. Experimental approaches to understanding virulence in toxoplasmosis. Immunobiology. 201:1999;210-214
26. Sinai A.P., Payne T.M., Carmen J.C., Hardi L.S., Watson J., Molestina R.E. Mechanisms underlying the manipulation of host apoptotic pathways by Toxoplasma gondii. Int. J. Parasitol. 34:2004;381-391
27. Su C., Howe D.K., Dubey J.P., Ajioka J.W., Sibley L.D. Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc. Natl Acad. Sci. USA. 99:2002;10753-10758
28. William S., Sabra A., Ramzy F., Mousa M., Demerdash Z., Benett J.L., Day T.A., Botros S. Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int. J. Parasitol. 31:2001;1093-1100